Company / Current Assets per Share
Syndax Pharmaceuticals Inc Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$6.16
FY2025
5-year range
$6.16 / $9.36
FY2021-FY2025
Trend
-13.3%
vs FY2024
Sector context
#118 of 210
Health Care
What the data says
At $6.16, Syndax Pharmaceuticals Inc's current assets per share ranks #118 of 210 in the Health Care sector. Current Assets per Share has declined for 5 consecutive years, from $11.01 in FY2020 to $6.16 in FY2025.
Based on SEC 10-K filings.
6.16 in FY2025 with a 5-year CAGR of -11.0%.
Declined from $8.53 to $6.16 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -11.6%
- 5-Year CAGR
- -11.0%
- 10-Year CAGR
- -
Sector benchmark
#118 of 210 in Health CareTop 56% of 210This company $6.16 Sector average $170.65
▼
-96.4% below sector average
Key checks
Key Insights
- Syndax Pharmaceuticals Inc's current assets per share has declined for 5 consecutive years.
- In FY2025, current assets per share decreased 13.3% year-over-year.
- Ranks #118 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.08 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.16 | -13.3% |
| FY2024 | $7.11 | -16.6% |
| FY2023 | $8.53 | -4.3% |
| FY2022 | $8.91 | -4.9% |
| FY2021 | $9.36 | -15.0% |
| FY2020 | $11.01 | +338.8% |
| FY2019 | $2.51 | -26.6% |
| FY2018 | $3.42 | -53.4% |
| FY2017 | $7.33 | -99.4% |
| FY2016 | $1270.01 | -1.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026